Linagliptin and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Linagliptin (linagliptin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have High blood pressure.

The phase IV clinical study analyzes which people have Overdose when taking Linagliptin. It is created by eHealthMe based on reports of 8,096 people who have side effects when taking Linagliptin from the FDA, and is updated regularly.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.

What is Overdose?

Overdose is found to be associated with 2,212 drugs and 2,475 conditions by eHealthMe. Check the latest studies of Overdose.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

8,096 people reported to have side effects when taking Linagliptin.
Among them, 70 people (0.86%) have Overdose.

Among these 70 people:

How long have people been on Linagliptin when they have Overdose? *

What is the gender of people who have Overdose when taking Linagliptin? *

female: 30.51 %
male: 69.49 %

What is the age of people who have Overdose when taking Linagliptin? *

What are other drugs people take besides Linagliptin? *

What are other side effects people have besides Overdose? *

Lactic Acidosis (low ph in body tissues): 20 people, 28.57%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 19 people, 27.14%
Hyperglycemia (high blood sugar): 12 people, 17.14%
Fatigue (feeling of tiredness): 11 people, 15.71%
High Blood Cholesterol: 11 people, 15.71%
High Blood Pressure: 10 people, 14.29%
Acute Kidney Failure: 9 people, 12.86%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 8 people, 11.43%
Hyperlactacidaemia (the acidosis and also reduces the capacity of the kidney): 7 people, 10.00%
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system): 7 people, 10.00%

What are the existing conditions these people have? *

Diabetes: 25 people, 35.71%
High Blood Pressure: 25 people, 35.71%
Type 2 Diabetes: 15 people, 21.43%
High Blood Cholesterol: 15 people, 21.43%
Insomnia (sleeplessness): 12 people, 17.14%
Enlarged Prostate: 11 people, 15.71%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 11 people, 15.71%
Dyslipidaemia (abnormal amount of lipids): 7 people, 10.00%
Viral Infection: 6 people, 8.57%
Gout (uric acid crystals building up in the body): 6 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Linagliptin and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Linagliptin:

Linagliptin (8,112 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Linagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,212 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,475 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linagliptin (the active ingredients of Linagliptin) and Linagliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.